Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.
- Revenue: $85.39M. Running result $85.39M. Laboratory Services: $85.36M. Therapeutic Development: $30K.
- Cost of revenue: −$59.71M. Running result $25.68M.
- Gross profit: $25.68M. Running result $25.68M.
- Research and development: −$14.55M. Running result $11.13M.
- Selling and marketing: −$15.23M. Running result −$4.1M.
- General and administrative: −$27.2M. Running result −$31.3M.
- Amortization of intangible assets: −$2.6M. Running result −$33.9M.
- Intangible impairment loss: −$2.17M. Running result −$36.07M.
- Equity securities impairment loss: $0. Running result −$36.07M.
- Operating income: −$36.07M. Running result −$36.07M.
- Other income: $6.38M. Running result −$29.69M.
- Pre-tax loss: −$29.69M. Running result −$29.69M.
- Income tax expense: −$29K. Running result −$29.72M.
- Net loss: −$29.72M. Running result −$29.72M.
